Drug Approval | August 17, 2023
Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
The company has secured 506 marketing approvals for its oncology products across 76 countries.
Marks the World Head & Neck Cancer Day at the OCTF Conference
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
Subscribe To Our Newsletter & Stay Updated
